ImmunoMet is Biotechnology in United States that focus on metabolic regulators business. Founded in 2015. They cover business area such as developer, novel anti, immuno-oncology, therapy, cancer patient, oncology drug, metabolic regulator, patient survival, cancer metabolism, anti-cancer immunity, drug-resistant cancer subpopulation, immuno-suppressor, healthcare provider, long-term survival, quality, life.
2015
( 9 years old in 2024 )
Metabolic Regulators
-
JLABS at Texas Medical Center
2450 Holcombe Boulevard
Houston, TX 77021
United States
Private
developernovel antiimmuno-oncologytherapycancer patientoncology drugmetabolic regulatorpatient survivalcancer metabolismanti-cancer immunitydrug-resistant cancer subpopulationimmuno-suppressorhealthcare providerlong-term survivalqualitylife
* We use standard office opening hours in near ImmunoMet's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ImmunoMet is Biotechnology business from United States that founded in 2015 (9 years old in 2024), ImmunoMet business is focusing on Metabolic Regulators.
ImmunoMet headquarter office and corporate office address is located in JLABS at Texas Medical Center 2450 Holcombe Boulevard Houston, TX 77021 United States.
ImmunoMet was founded in United States.
In 2024, ImmunoMet is currently focus on metabolic regulators sector.
Above is snippet of Google Trends for "metabolic regulators" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ImmunoMet, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
